Roche launched the "Digital Healthcare Incubator 2.0" at the seventh China International Import Expo in Shanghai. [Photo ...

An attempt by Roche, a Swiss pharmaceuticals firm, to prevent India’s Natco Pharma from introducing a generic version of a ...

Switzerland is generally considered an attractive place to live and work in, but what specific benefits are foreigners ...

Swiss Re, Zurich Insurance Group, SGS, Swisscom and UBS Group drifted down 1.5 to 2%. Nestle, Lindt & Spruengli, Kuehne + Nagel, Roche Holding and VAT Group ended lower by 1 to 1.3%. Lonza Group ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

With only a few days to go before the US presidential elections, new data has been released about the American citizens who ...

Discover the benefits of international dividend plays with HDEF, with a focus on Financials and Consumer Staples, offering ...

Dyno Therapeutics has recently announced the formation of a new strategic partnership with Swiss pharma giant Roche to ...

This year has seen several biopharma companies drop Alzheimer’s and Parkinson’s disease programs, but experts say plenty are ...

With U.S. sales of $392 million in the third quarter, Regeneron’s high-dose version of Eylea is closing in on blockbuster sales in its first full year on the market. The bad news for the company, ...

Swatch Group ended down 2.5%. Novartis, Roche Holding, Kuehne + Nagel, Givaudan, Nestle, Sandoz Group and Swisscom lost 1 to 1.7%. ABB climbed 2.51%. UBS Group gained 1.86%, and Holcim closed up 1.64% ...